These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 11802962)
1. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions]. Yang Z; Xie C Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H; Rona G; Hutter C; Bayer PM; Kummer F Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811 [TBL] [Abstract][Full Text] [Related]
3. Comparison of telomerase activity between malignant and tuberculous pleural effusions. Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245 [TBL] [Abstract][Full Text] [Related]
4. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Lee WY Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients. Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365 [TBL] [Abstract][Full Text] [Related]
6. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions. Gaspar MJ; De Miguel J; García Díaz JD; Díez M Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma. Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]. Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362 [TBL] [Abstract][Full Text] [Related]
10. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Li CS; Cheng BC; Ge W; Gao JF Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612 [TBL] [Abstract][Full Text] [Related]
11. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916 [TBL] [Abstract][Full Text] [Related]
12. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion]. Li YP; Hu CP; Yang HZ Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317 [TBL] [Abstract][Full Text] [Related]
14. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A; Lynne LC; Howell L Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of four tumor markers in malignant and benign pleural effusions. Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419 [TBL] [Abstract][Full Text] [Related]
16. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions. Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354 [TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in pleural effusions: diagnostic significance. Yang CT; Lee MH; Lan RS; Chen JK J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion. Sthaneshwar P; Yap SF; Jayaram G Malays J Pathol; 2002 Jun; 24(1):53-8. PubMed ID: 16329556 [TBL] [Abstract][Full Text] [Related]
19. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions. Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169 [TBL] [Abstract][Full Text] [Related]
20. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions. Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]